xy03-ea
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Oct 30, 2022 (NCT05515393)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06755944 | Phase 2/Phase 3 (Phase 3) | Dec 15, 2024 | Yiling Pharmaceutical Inc. |
| NCT05515393 | Phase 2 | Oct 30, 2022 | Sun Yat-Sen University, Yiling Pharmaceutical Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Yiling Pharmaceutical Inc. | For profit | 2 | 2 | 2 | 2022 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 0 | 1 | 2022 |
2 organizations
Page 1 / 1